PAVmed Announces PortIO™ Breakthrough
13 mars 2019 08h04 HE
|
PAVmed Inc.
Groundbreaking implantable intraosseous vascular access device achieves unprecedented maintenance-free implant duration of over 60 days in pre-clinical testing NEW YORK, March 13, 2019 (GLOBE...